Clinical Trial
Feprazone compared with indomethacin in the management of rheumatoid arthritis
- PMID: 1103113
Item in Clipboard
Clinical Trial
Feprazone compared with indomethacin in the management of rheumatoid arthritis
Practitioner.
1975 Jul.
Abstract
A double-blind cross-over trial of feprazone 450 mg daily and indomethacin 75 mg daily was carried out in fourteen patients with rheumatoid arthritis. The analgesic and anti-inflammatory activity was indistinguishable from that of indomethacin under the conditions of the trial. Seven patients expressed a preference for feprazone and four for indomethacin. Feprazone appeared to be well tolerated and free from serious side-effects. These results suggest that feprazone will be a useful drug in the management of rheumatoid arthritis.
Similar articles
-
Safety and efficacy of feprazone for long-term treatment of rheumatoid arthritis and osteoarthritis.Clin Ther. 1981;3(5):349-55. Clin Ther. 1981. PMID: 7471130
-
[Results of an open study and a controlled comparative study of feprazone and naproxen in patients with rheumatoid arthritis or osteoarthrosis (author's transl)].Wien Med Wochenschr. 1981 Dec 31;131(23-24):597-601. Wien Med Wochenschr. 1981. PMID: 7039147 Clinical Trial. German.
-
[Clinical evaluation of feprazone in rheumatoid arthritis (author's transl)].Ryumachi. 1979 Apr;19(2):147-63. Ryumachi. 1979. PMID: 375431 Clinical Trial. Japanese. No abstract available.
-
[Determination of effects of drug therapy in chronic rheumatoid arthritis--problems in determination of therapeutic effects of anti-rheumatoid drugs].Naika. 1970;25(5):896-906. Naika. 1970. PMID: 4914391 Review. Japanese. No abstract available.
-
[Pharmacodynamics and adverse effects of modern nonsteroid anti-inflammatory agents].Ter Arkh. 1981;53(7):142-51. Ter Arkh. 1981. PMID: 6457407 Review. Russian. No abstract available.
Cited by
-
An analysis of the gastro-intestinal side-effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species.Rheumatol Int. 1982;2(1):1-10. doi: 10.1007/BF00541263. Rheumatol Int. 1982. PMID: 7178760
-
Feprazone Mitigates IL-1β-Induced Cellular Senescence in Chondrocytes.ACS Omega. 2021 Mar 31;6(14):9442-9448. doi: 10.1021/acsomega.0c06066. eCollection 2021 Apr 13. ACS Omega. 2021. PMID: 33869924 Free PMC article.
-
Rectal administration of feprazone in healthy volunteers.Br J Clin Pharmacol. 1976 Apr;3(2):339-40. doi: 10.1111/j.1365-2125.1976.tb00616.x. Br J Clin Pharmacol. 1976. PMID: 973970 Free PMC article. Clinical Trial. No abstract available.